160 related articles for article (PubMed ID: 37854213)
41. Microarray-Based Detection of Critical Overexpressed Genes in the Progression of Hepatic Fibrosis in Non-Alcoholic Fatty Liver Disease: A Protein-Protein Interaction Network Analysis.
Mahmoudi A; Butler AE; De Vincentis A; Jamialahmadi T; Sahebkar A
Curr Med Chem; 2023 May; ():. PubMed ID: 37194229
[TBL] [Abstract][Full Text] [Related]
42. Versican and its associated molecules: potential diagnostic markers for multiple myeloma.
Gupta N; Khan R; Kumar R; Kumar L; Sharma A
Clin Chim Acta; 2015 Mar; 442():119-24. PubMed ID: 25623955
[TBL] [Abstract][Full Text] [Related]
43. N6-Methyladenosine-Related LncRNAs Are Potential Remodeling Indicators in the Tumor Microenvironment and Prognostic Markers in Osteosarcoma.
Wu Z; Zhang X; Chen D; Li Z; Wu X; Wang J; Deng Y
Front Immunol; 2021; 12():806189. PubMed ID: 35095893
[TBL] [Abstract][Full Text] [Related]
44. LRH1 Acts as an Oncogenic Driver in Human Osteosarcoma and Pan-Cancer.
Song Y; An W; Wang H; Gao Y; Han J; Hao C; Chen L; Liu S; Xing Y
Front Cell Dev Biol; 2021; 9():643522. PubMed ID: 33791301
[TBL] [Abstract][Full Text] [Related]
45. A Pan-Cancer Analysis of the Oncogenic Role of
Yang D; Li H; Chen Y; Li C; Ren W; Huang Y
Front Genet; 2022; 13():906174. PubMed ID: 35910232
[No Abstract] [Full Text] [Related]
46. Expression of miR‑542‑3p in osteosarcoma with miRNA microarray data, and its potential signaling pathways.
Li Z; Yao JN; Huang WT; He RQ; Ma J; Chen G; Wei QJ
Mol Med Rep; 2019 Feb; 19(2):974-983. PubMed ID: 30569116
[TBL] [Abstract][Full Text] [Related]
47. Multi-omics analysis of the oncogenic value of copper Metabolism-Related protein COMMD2 in human cancers.
Tai P; Wang Z; Chen X; Chen A; Gong L; Cheng Y; Cao K
Cancer Med; 2023 May; 12(10):11941-11959. PubMed ID: 36205192
[TBL] [Abstract][Full Text] [Related]
48. A Pan-Cancer Analysis Reveals the Prognostic and Immunotherapeutic Value of Stanniocalcin-2 (STC2).
Jiang ZH; Shen X; Wei Y; Chen Y; Chai H; Xia L; Leng W
Front Genet; 2022; 13():927046. PubMed ID: 35937984
[No Abstract] [Full Text] [Related]
49. Versican and vascular endothelial growth factor expression levels in peritoneal metastases from colorectal cancer are associated with survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Sluiter NR; de Cuba EM; Kwakman R; Meijerink WJ; Delis-van Diemen PM; Coupé VM; Beliën JA; Meijer GA; de Hingh IH; te Velde EA
Clin Exp Metastasis; 2016 Apr; 33(4):297-307. PubMed ID: 26873137
[TBL] [Abstract][Full Text] [Related]
50. [Expression of Versican and Its Related Molecules in Patient with Multiple Myeloma and Its Clinical Significance].
Wu YQ; Luo LY; Tang YN; Li HJ; Li YJ; Wang Y; Yao Y; Li DP; Xu KL; Li ZY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Aug; 28(4):1228-1233. PubMed ID: 32798403
[TBL] [Abstract][Full Text] [Related]
51. Comprehensive pan-cancer analysis and the regulatory mechanism of AURKA, a gene associated with prognosis of ferroptosis of adrenal cortical carcinoma in the tumor micro-environment.
Lu K; Yuan X; Zhao L; Wang B; Zhang Y
Front Genet; 2022; 13():996180. PubMed ID: 36685952
[No Abstract] [Full Text] [Related]
52. N6-methyladenosine Modification-Related Long Non-Coding RNAs are Potential Biomarkers for Predicting the Prognosis of Patients With Osteosarcoma.
Yang K; Wang F; Li K; Peng G; Yang H; Xu H; Xiang Y; Sun H
Technol Cancer Res Treat; 2022; 21():15330338221085354. PubMed ID: 35422168
[No Abstract] [Full Text] [Related]
53. Glucocorticoid signalling drives reduced versican levels in the fetal mouse lung.
Short KL; Bird AD; Seow BKL; Ng J; McDougall ARA; Wallace MJ; Hooper SB; Cole TJ
J Mol Endocrinol; 2020 Apr; 64(3):155-164. PubMed ID: 31958317
[TBL] [Abstract][Full Text] [Related]
54. VCAN, expressed highly in hepatitis B virus-induced hepatocellular carcinoma, is a potential biomarker for immune checkpoint inhibitors.
Wang MQ; Li YP; Xu M; Tian Y; Wu Y; Zhang X; Shi JJ; Dang SS; Jia XL
World J Gastrointest Oncol; 2022 Oct; 14(10):1933-1948. PubMed ID: 36310697
[TBL] [Abstract][Full Text] [Related]
55. Comprehensive landscape of the miRNA-regulated prognostic marker LAYN with immune infiltration and stemness in pan-cancer.
Jiawen W; Jinfu W; Jianyong L; Yaoguang Z; Jianye W
J Cancer Res Clin Oncol; 2023 Oct; 149(13):10989-11011. PubMed ID: 37335337
[TBL] [Abstract][Full Text] [Related]
56. Identification and Validation of Three PDAC Subtypes and Individualized GSVA Immune Pathway-Related Prognostic Risk Score Formula in Pancreatic Ductal Adenocarcinoma Patients.
Zhang D; Wang M; Peng L; Yang X; Li K; Yin H; Xia C; Cui F; Huang H; Jin Z
J Oncol; 2021; 2021():4986227. PubMed ID: 34987579
[TBL] [Abstract][Full Text] [Related]
57. Identification of metastasis and prognosis-associated genes for serous ovarian cancer.
Yang Y; Qi S; Shi C; Han X; Yu J; Zhang L; Qin S; Gao Y
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32510146
[TBL] [Abstract][Full Text] [Related]
58. Overexpressed versican promoted cell multiplication, migration and invasion in gastric cancer.
Zhai L; Chen W; Cui B; Yu B; Wang Y; Liu H
Tissue Cell; 2021 Dec; 73():101611. PubMed ID: 34358918
[TBL] [Abstract][Full Text] [Related]
59. Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management.
Maruschke M; Reuter D; Koczan D; Hakenberg OW; Thiesen HJ
BJU Int; 2011 Jul; 108(2 Pt 2):E29-35. PubMed ID: 21435154
[TBL] [Abstract][Full Text] [Related]
60. Computational analysis for identification of the extracellular matrix molecules involved in endometrial cancer progression.
Yadav VK; Lee TY; Hsu JB; Huang HD; Yang WV; Chang TH
PLoS One; 2020; 15(4):e0231594. PubMed ID: 32315343
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
